NCT01020214View on ClinicalTrials.gov

Fasting Study of Olmesartan Medoxomil and Hydrochlorothiazide Tablets 40 mg/25 mg and Benicar HCT® Tablets 40 mg/25 mg

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions
Healthy
Interventions
DRUG

Olmesartan Medoxomil and Hydrochlorothiazide Tablets 40 mg/25 mg

DRUG

Benicar HCT® Tablets 40 mg/25 mg

Trial Locations (1)

58104

PRACS Institute Ltd., Fargo

Sponsors
All Listed Sponsors
lead

Mylan Pharmaceuticals Inc

INDUSTRY